✉news BusinessRetail first seen 12 h ago, last 7 h ago, peak #6
ImmunityBio Stock Slips as Retail Investors Call It a Bargain
Original: IBRX Stock Under Pressure: Retail Sees 'Ridiculously Cheap' Bargain As Founder Touts Sister Firm NantIQ's Aetna Work
ImmunityBio (IBRX) shares are under pressure, but retail investors are calling the stock 'ridiculously cheap' and buying the dip. Attention has also turned to founder Soon-Shiong promoting the work of sister company NantIQ with insurer Aetna. The debate over whether IBRX is undervalued or facing genuine headwinds is dividing retail sentiment.
Why now: Retail investors are actively debating whether ImmunityBio's falling share price represents a buying opportunity.
ImmunityBioIBRXNantIQAetnaPatrick Soon-Shiong
Evidence
- IBRX Stock Under Pressure: Retail Sees 'Ridiculously Cheap' Bargain As Founder Touts Sister Firm NantIQ's Aetna Work · Stocktwits
API: https://socialmediatrends-api.osmike.com/v1/trends/1463992